Table 2.
Association with between polymorphisms of MIR17HG and colorectal cancer risk
| SNP‐ID | Chr | Position |
Alleles A/B |
MAF | OR (95% CI) | p | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| rs72640334 | 13 | 91352674 | A/C | 0.084 | 0.096 | 0.86 (0.64–1.17) | 0.341 |
| rs7336610 | 13 | 91352883 | T/C | 0.554 | 0.495 | 1.27 (1.07–1.51) | 0.007 |
| rs7318578 | 13 | 91353215 | C/A | 0.263 | 0.297 | 0.85 (0.70–1.03) | 0.089 |
| rs17735387 | 13 | 91353800 | A/G | 0.164 | 0.188 | 0.85 (0.68–1.07) | 0.157 |
| rs1428 | 13 | 91354516 | A/C | 0.555 | 0.496 | 1.27 (1.06–1.51) | 0.008 |
SNP: Single nucleotide polymorphism; Chr: chromosome; A: Minor alleles; B: Major alleles; MAF: Minor allele frequency; OR: Odds ratio; 95% CI: 95% Confidence interval
p values were calculated from χ 2 test ( two sided).
p < 0.05 was considered statistically significant.